Detailed information for compound 258302

Basic information

Technical information
  • TDR Targets ID: 258302
  • Name: (3S)-3-(5-phenethylpyridin-3-yl)-3-[[(3R)-1-( 3-piperidin-4-ylpropanoyl)piperidine-3-carbon yl]amino]propanoic acid
  • MW: 520.663 | Formula: C30H40N4O4
  • H donors: 3 H acceptors: 5 LogP: -0.01 Rotable bonds: 13
    Rule of 5 violations (Lipinski): 2
  • SMILES: OC(=O)C[C@@H](c1cncc(c1)CCc1ccccc1)NC(=O)[C@@H]1CCCN(C1)C(=O)CCC1CCNCC1
  • InChi: 1S/C30H40N4O4/c35-28(11-10-23-12-14-31-15-13-23)34-16-4-7-25(21-34)30(38)33-27(18-29(36)37)26-17-24(19-32-20-26)9-8-22-5-2-1-3-6-22/h1-3,5-6,17,19-20,23,25,27,31H,4,7-16,18,21H2,(H,33,38)(H,36,37)/t25-,27+/m1/s1
  • InChiKey: HIASMCVWLMTBEO-VPUSJEBWSA-N  

Network

Hover on a compound node to display the structore

Synonyms

  • (3S)-3-(5-phenethyl-3-pyridyl)-3-[[(3R)-1-[3-(4-piperidyl)propanoyl]piperidine-3-carbonyl]amino]propanoic acid
  • (3S)-3-[[oxo-[(3R)-1-[1-oxo-3-(4-piperidinyl)propyl]-3-piperidinyl]methyl]amino]-3-(5-phenethyl-3-pyridyl)propanoic acid
  • (3S)-3-(5-phenethylpyridin-3-yl)-3-[[(3R)-1-(3-piperidin-4-ylpropanoyl)piperidin-3-yl]carbonylamino]propanoic acid
  • (3S)-3-(5-phenethyl-3-pyridyl)-3-[[(3R)-1-[3-(4-piperidyl)propanoyl]nipecotoyl]amino]propionic acid
  • (3S)-3-[5-(2-phenylethyl)pyridin-3-yl]-3-[[(3R)-1-(3-piperidin-4-ylpropanoyl)piperidine-3-carbonyl]amino]propanoic acid
  • (3S)-3-[5-(2-phenylethyl)-3-pyridyl]-3-[[(3R)-1-[3-(4-piperidyl)propanoyl]piperidine-3-carbonyl]amino]propanoic acid
  • (3S)-3-[[oxo-[(3R)-1-[1-oxo-3-(4-piperidinyl)propyl]-3-piperidinyl]methyl]amino]-3-[5-(2-phenylethyl)-3-pyridyl]propanoic acid
  • (3S)-3-[5-(2-phenylethyl)-3-pyridyl]-3-[[(3R)-1-[3-(4-piperidyl)propanoyl]piperidine-3-carbonyl]amino]propionic acid
  • (3S)-3-[5-(2-phenylethyl)pyridin-3-yl]-3-[[(3R)-1-(3-piperidin-4-ylpropanoyl)piperidin-3-yl]carbonylamino]propanoic acid

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Homo sapiens integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41) Starlite/ChEMBL References
Homo sapiens integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61) References

Predicted pathogen targets for this compound

By orthology
Species Potential target Known druggable target/s Ortholog Group
Schistosoma japonicum ko:K06464 integrin beta 2, putative Get druggable targets OG5_127959 All targets in OG5_127959
Echinococcus multilocularis integrin beta 2 Get druggable targets OG5_127959 All targets in OG5_127959
Echinococcus granulosus integrin beta 2 Get druggable targets OG5_127959 All targets in OG5_127959
Schistosoma japonicum ko:K06476 integrin alpha 2B, putative Get druggable targets OG5_129341 All targets in OG5_129341
Brugia malayi Integrin alpha pat-2 precursor Get druggable targets OG5_129341 All targets in OG5_129341
Schistosoma mansoni integrin alpha Get druggable targets OG5_129341 All targets in OG5_129341
Brugia malayi Integrin beta pat-3 precursor Get druggable targets OG5_127959 All targets in OG5_127959
Loa Loa (eye worm) integrin beta-2 Get druggable targets OG5_127959 All targets in OG5_127959
Schistosoma japonicum Integrin beta-3 precursor, putative Get druggable targets OG5_127959 All targets in OG5_127959
Schistosoma japonicum Integrin beta-PS precursor, putative Get druggable targets OG5_127959 All targets in OG5_127959
Echinococcus multilocularis integrin alpha 3 Get druggable targets OG5_129341 All targets in OG5_129341
Schistosoma mansoni integrin beta subunit Get druggable targets OG5_127959 All targets in OG5_127959
Schistosoma japonicum IPR013513,Integrin alpha chain, C-terminal cytoplasmic region,domain-containing Get druggable targets OG5_129341 All targets in OG5_129341
Echinococcus granulosus integrin alpha 3 Get druggable targets OG5_129341 All targets in OG5_129341
Loa Loa (eye worm) hypothetical protein Get druggable targets OG5_129341 All targets in OG5_129341
Loa Loa (eye worm) integrin alpha pat-2 Get druggable targets OG5_129341 All targets in OG5_129341
Loa Loa (eye worm) hypothetical protein Get druggable targets OG5_129341 All targets in OG5_129341

By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Trichomonas vaginalis fructose-bisphosphate aldolase, putative 0.0307 0.1602 0.3505
Brugia malayi Integrin alpha pat-2 precursor 0.0185 0.0869 0.3506
Mycobacterium ulcerans penicillin-binding lipoprotein 0.0314 0.1642 0.1887
Mycobacterium leprae Probable penicillin-binding membrane protein PbpB 0.0464 0.2543 0.3654
Schistosoma mansoni integrin alpha-ps 0.0083 0.0258 0.1741
Schistosoma mansoni tyrosyl-DNA phosphodiesterase 0.0134 0.0567 0.3822
Trichomonas vaginalis fructose-bisphosphate aldolase, putative 0.0307 0.1602 0.3505
Brugia malayi Pre-SET motif family protein 0.042 0.2281 1
Echinococcus granulosus integrin alpha ps 0.0083 0.0258 0.1792
Schistosoma mansoni 3-hydroxyacyl-CoA dehydrogenase 0.0117 0.0462 0.3112
Schistosoma mansoni lipoxygenase 0.0087 0.0281 0.1897
Echinococcus granulosus tyrosyl DNA phosphodiesterase 1 0.0134 0.0567 0.3933
Echinococcus granulosus histone lysine methyltransferase setb 0.006 0.0123 0.0857
Schistosoma mansoni integrin beta subunit 0.0223 0.1097 0.7395
Schistosoma mansoni integrin alpha-ps 0.0043 0.0021 0.0138
Loa Loa (eye worm) kelch domain-containing protein family protein 0.0057 0.0107 0.0467
Loa Loa (eye worm) glutaminase 0.0287 0.1483 0.6503
Echinococcus multilocularis integrin alpha ps 0.0083 0.0258 0.1792
Treponema pallidum penicillin-binding protein (pbp-3) 0.1477 0.8611 0.8346
Echinococcus granulosus 3 hydroxyacyl coenzyme A dehydrogenase type 2 0.0117 0.0462 0.3202
Loa Loa (eye worm) hypothetical protein 0.0043 0.0021 0.009
Schistosoma mansoni histone-lysine n-methyltransferase setb1 0.006 0.0123 0.0832
Loa Loa (eye worm) hypothetical protein 0.0145 0.0631 0.2767
Mycobacterium tuberculosis Probable penicillin-binding membrane protein PbpB 0.0464 0.2543 0.3891
Treponema pallidum penicillin-binding protein (pbp-2) 0.0796 0.4534 0.3491
Trichomonas vaginalis conserved hypothetical protein 0.0796 0.4534 1
Mycobacterium leprae PROBABLE BIFUNCTIONAL PENICILLIN-BINDING PROTEIN 1A/1B PONA1 (MUREIN POLYMERASE) (PBP1): PENICILLIN-INSENSITIVE TRANSGLYCOSYLASE 0.0796 0.4534 0.7518
Echinococcus granulosus L aminoadipate semialdehyde 0.0087 0.0286 0.1982
Trichomonas vaginalis fructose-bisphosphate aldolase, putative 0.0307 0.1602 0.3505
Schistosoma mansoni histone-lysine n-methyltransferase setb1 0.006 0.0123 0.0832
Trichomonas vaginalis fructose-bisphosphate aldolase, putative 0.0307 0.1602 0.3505
Wolbachia endosymbiont of Brugia malayi cell division protein FtsI 0.1708 1 0.5
Echinococcus multilocularis integrin beta 2 0.028 0.1441 1
Echinococcus multilocularis arachidonate 5 lipoxygenase 0.0124 0.0505 0.3502
Brugia malayi Tyrosyl-DNA phosphodiesterase family protein 0.0134 0.0567 0.2117
Giardia lamblia Fructose-bisphosphate aldolase 0.0307 0.1602 0.5
Plasmodium vivax SET domain protein, putative 0.006 0.0123 0.5
Mycobacterium ulcerans bifunctional membrane-associated penicillin-binding protein 1A/1B PonA2 0.0548 0.3047 0.3523
Trichomonas vaginalis fructose-bisphosphate aldolase, putative 0.0307 0.1602 0.3505
Schistosoma mansoni glutaminase 0.0287 0.1483 1
Echinococcus granulosus dna polymerase kappa 0.0043 0.0021 0.0144
Trypanosoma cruzi tyrosyl-DNA Phosphodiesterase (Tdp1), putative 0.0134 0.0567 1
Toxoplasma gondii histone lysine methyltransferase SET/SUV39 0.006 0.0123 0.5
Brugia malayi Integrin beta pat-3 precursor 0.0378 0.2029 0.8841
Mycobacterium ulcerans bifunctional penicillin-binding protein 1A/1B PonA1 0.0796 0.4534 0.5254
Onchocerca volvulus 0.0087 0.0286 0.0647
Trichomonas vaginalis glutaminase, putative 0.0287 0.1483 0.3241
Entamoeba histolytica fructose-1,6-bisphosphate aldolase, putative 0.0307 0.1602 1
Entamoeba histolytica fructose-1,6-bisphosphate aldolase, putative 0.0307 0.1602 1
Loa Loa (eye worm) 3-hydroxyacyl-CoA dehydrogenase type II 0.0109 0.0414 0.1817
Echinococcus multilocularis transcription factor Dp 1 0.0078 0.0228 0.1582
Schistosoma mansoni integrin alpha 0.0185 0.0869 0.5857
Echinococcus multilocularis histone lysine methyltransferase setb histone lysine methyltransferase eggless 0.006 0.0123 0.0857
Brugia malayi Integrin alpha cytoplasmic region family protein 0.014 0.0599 0.2266
Trichomonas vaginalis set domain proteins, putative 0.0478 0.2629 0.5779
Mycobacterium ulcerans short-chain type dehydrogenase/reductase 0.0117 0.0462 0.0513
Loa Loa (eye worm) hypothetical protein 0.006 0.0123 0.0541
Loa Loa (eye worm) hypothetical protein 0.0102 0.0373 0.1634
Leishmania major tyrosyl-DNA phosphodiesterase 1 0.0134 0.0567 1
Echinococcus granulosus integrin alpha 3 0.0142 0.0611 0.4236
Trypanosoma brucei tyrosyl-DNA Phosphodiesterase (Tdp1), putative 0.0134 0.0567 1
Echinococcus multilocularis dna polymerase kappa 0.0043 0.0021 0.0144
Loa Loa (eye worm) glutaminase 2 0.0287 0.1483 0.6503
Mycobacterium ulcerans short-chain type dehydrogenase/reductase 0.0117 0.0462 0.0513
Mycobacterium tuberculosis Possible penicillin-binding lipoprotein 0.0314 0.1642 0.2206
Trichomonas vaginalis fructose-bisphosphate aldolase, putative 0.0307 0.1602 0.3505
Mycobacterium tuberculosis Probable penicillin-binding protein PbpA 0.101 0.5812 1
Onchocerca volvulus 0.0478 0.2629 1
Schistosoma mansoni lipoxygenase 0.0124 0.0505 0.3403
Brugia malayi aminoadipate-semialdehyde dehydrogenase-phosphopantetheinyl transferase 0.0087 0.0286 0.0824
Loa Loa (eye worm) hypothetical protein 0.0087 0.0286 0.1252
Mycobacterium tuberculosis Probable bifunctional penicillin-binding protein 1A/1B PonA1 (murein polymerase) (PBP1): penicillin-insensitive transglycosylase 0.0248 0.1249 0.1472
Schistosoma mansoni aminoadipate-semialdehyde dehydrogenase 0.0087 0.0286 0.1926
Loa Loa (eye worm) integrin beta-2 0.0378 0.2029 0.8895
Mycobacterium leprae PROBABLE BIFUNCTIONAL MEMBRANE-ASSOCIATED PENICILLIN-BINDING PROTEIN 1A/1B PONA2 (MUREIN POLYMERASE) [INCLUDES: PENICILLIN-INSEN 0.0548 0.3047 0.4631
Loa Loa (eye worm) hypothetical protein 0.014 0.0599 0.2627
Echinococcus granulosus integrin beta 2 0.028 0.1441 1
Schistosoma mansoni histone-lysine n-methyltransferase suv9 0.006 0.0123 0.0832
Mycobacterium ulcerans glutaminase 0.0287 0.1483 0.1703
Loa Loa (eye worm) hypothetical protein 0.0057 0.0107 0.0467
Loa Loa (eye worm) pre-SET domain-containing protein family protein 0.042 0.2281 1
Echinococcus multilocularis integrin alpha ps 0.0083 0.0258 0.1792
Echinococcus multilocularis L aminoadipate semialdehyde 0.0087 0.0286 0.1982
Schistosoma mansoni histone-lysine n-methyltransferase setb1 0.006 0.0123 0.0832
Mycobacterium ulcerans penicillin-binding membrane protein PbpB 0.1477 0.8611 1
Loa Loa (eye worm) integrin alpha pat-2 0.0285 0.1468 0.6436
Echinococcus granulosus 5'partial|histone lysine N methyltransferase SETDB2 0.0058 0.011 0.0764
Mycobacterium ulcerans fructose-bisphosphate aldolase 0.015 0.0661 0.0746
Brugia malayi 3-hydroxyacyl-CoA dehydrogenase type II 0.0117 0.0462 0.1632
Mycobacterium leprae Probable penicillin-binding protein PbpA 0.101 0.5812 1
Trichomonas vaginalis fructose-bisphosphate aldolase, putative 0.0307 0.1602 0.3505
Echinococcus multilocularis histone lysine N methyltransferase SETMAR 0.006 0.0123 0.0857
Echinococcus multilocularis 3 hydroxyacyl coenzyme A dehydrogenase type 2 0.0117 0.0462 0.3202
Mycobacterium leprae POSSIBLE PENICILLIN-BINDING LIPOPROTEIN 0.0314 0.1642 0.1904
Echinococcus multilocularis integrin alpha 3 0.0142 0.0611 0.4236
Trichomonas vaginalis fructose-bisphosphate aldolase, putative 0.0307 0.1602 0.3505
Mycobacterium ulcerans penicillin-binding protein PbpA 0.101 0.5812 0.6742
Echinococcus granulosus transcription factor Dp 1 0.0078 0.0228 0.1582
Echinococcus multilocularis tyrosyl DNA phosphodiesterase 1 0.0134 0.0567 0.3933
Treponema pallidum penicillin-binding protein (pbp-1) 0.1708 1 1
Mycobacterium tuberculosis Probable bifunctional membrane-associated penicillin-binding protein 1A/1B PonA2 (murein polymerase) [includes: penicillin-insen 0.0548 0.3047 0.4831
Mycobacterium tuberculosis Probable fructose-bisphosphate aldolase Fba 0.015 0.0661 0.0373
Brugia malayi glutaminase DH11.1 0.0287 0.1483 0.6332
Trypanosoma cruzi tyrosyl-DNA Phosphodiesterase (Tdp1), putative 0.0134 0.0567 1
Echinococcus granulosus arachidonate 5 lipoxygenase 0.0124 0.0505 0.3502
Loa Loa (eye worm) tyrosyl-DNA phosphodiesterase 0.0134 0.0567 0.2486
Brugia malayi Pre-SET motif family protein 0.006 0.0123 0.0078

Activities

Activity type Activity value Assay description Source Reference
Duration (functional) = 180 min Ex vivo duration of inhibition of ADP-induced canine platelet aggregation by 3 mg/kg. ChEMBL. 10602710
IC50 (binding) = 0.66 nM In vitro inhibition of biotinylated fibrinogen binding to immobolized fibrinogen receptor. ChEMBL. 10602710
IC50 (binding) = 0.66 nM In vitro inhibition of biotinylated fibrinogen binding to immobolized fibrinogen receptor. ChEMBL. 10602710
IC50 (functional) = 0.03 uM In vitro inhibitory potency against human gel filtered platelet (GFP) aggregation ChEMBL. 10602710
IC50 (functional) = 0.03 uM In vitro inhibitory potency against human gel filtered platelet (GFP) aggregation ChEMBL. 10602710

Phenotypes

Whole-cell/tissue/organism interactions

Species name Source Reference Is orphan
Homo sapiens ChEMBL23 10602710

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

1 literature reference was collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.